Annual CFI
-$21.35 B
-$19.06 B-830.37%
December 1, 2024
Summary
- As of February 26, 2025, BMY annual cash flow from investing activities is -$21.35 billion, with the most recent change of -$19.06 billion (-830.37%) on December 1, 2024.
- During the last 3 years, BMY annual CFI has fallen by -$20.81 billion (-3868.77%).
- BMY annual CFI is now -520.40% below its all-time high of $5.08 billion, reached on December 31, 2008.
Performance
BMY Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$196.00 M
+$23.00 M+10.50%
December 1, 2024
Summary
- As of February 26, 2025, BMY quarterly cash flow from investing activities is -$196.00 million, with the most recent change of +$23.00 million (+10.50%) on December 1, 2024.
- Over the past year, BMY quarterly CFI has increased by +$1.15 billion (+85.44%).
- BMY quarterly CFI is now -105.01% below its all-time high of $3.91 billion, reached on September 30, 2008.
Performance
BMY Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$21.35 B
+$1.15 B+5.11%
December 1, 2024
Summary
- As of February 26, 2025, BMY TTM cash flow from investing activities is -$21.35 billion, with the most recent change of +$1.15 billion (+5.11%) on December 1, 2024.
- Over the past year, BMY TTM CFI has dropped by -$19.06 billion (-830.37%).
- BMY TTM CFI is now -520.40% below its all-time high of $5.08 billion, reached on December 31, 2008.
Performance
BMY TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
BMY Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -830.4% | +85.4% | -830.4% |
| 3 y3 years | -3868.8% | +85.4% | -830.4% |
| 5 y5 years | -115.4% | +85.4% | -830.4% |
BMY Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -3868.8% | at low | -116.2% | +99.0% | -8187.9% | +5.9% |
| 5 y | 5-year | -3868.8% | at low | -116.2% | +99.0% | -8187.9% | +5.9% |
| alltime | all time | -520.4% | at low | -105.0% | +99.0% | -520.4% | +5.9% |
Bristol-Myers Squibb Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$21.35 B(+830.4%) | -$196.00 M(-10.5%) | -$21.35 B(-5.1%) |
| Sep 2024 | - | -$219.00 M(-83.4%) | -$22.50 B(-0.8%) |
| Jun 2024 | - | -$1.32 B(-93.3%) | -$22.69 B(+4.6%) |
| Mar 2024 | - | -$19.62 B(+1357.5%) | -$21.70 B(+845.7%) |
| Dec 2023 | -$2.29 B(+116.1%) | -$1.35 B(+228.3%) | -$2.29 B(-969.3%) |
| Sep 2023 | - | -$410.00 M(+24.6%) | $264.00 M(-118.8%) |
| Jun 2023 | - | -$329.00 M(+56.7%) | -$1.41 B(+2.9%) |
| Mar 2023 | - | -$210.00 M(-117.3%) | -$1.37 B(+28.7%) |
| Dec 2022 | -$1.06 B(+97.4%) | $1.21 B(-158.3%) | -$1.06 B(-43.3%) |
| Sep 2022 | - | -$2.08 B(+620.1%) | -$1.87 B(+143.7%) |
| Jun 2022 | - | -$289.00 M(-404.2%) | -$769.00 M(+156.3%) |
| Mar 2022 | - | $95.00 M(-76.3%) | -$300.00 M(-44.2%) |
| Dec 2021 | -$538.00 M(-95.0%) | $401.00 M(-141.1%) | -$538.00 M(-95.8%) |
| Sep 2021 | - | -$976.00 M(-642.2%) | -$12.75 B(+6.4%) |
| Jun 2021 | - | $180.00 M(-225.9%) | -$11.99 B(+3.2%) |
| Mar 2021 | - | -$143.00 M(-98.8%) | -$11.61 B(+6.9%) |
| Dec 2020 | -$10.86 B(+9.5%) | -$11.81 B(+5445.5%) | -$10.86 B(-3.3%) |
| Sep 2020 | - | -$213.00 M(-138.3%) | -$11.23 B(+6.7%) |
| Jun 2020 | - | $556.00 M(-8.9%) | -$10.52 B(+1.5%) |
| Mar 2020 | - | $610.00 M(-105.0%) | -$10.36 B(+4.5%) |
| Dec 2019 | -$9.91 B(+395.7%) | -$12.18 B(-2580.4%) | -$9.91 B(-1333.0%) |
| Sep 2019 | - | $491.00 M(-31.3%) | $804.00 M(+384.3%) |
| Jun 2019 | - | $715.00 M(-32.5%) | $166.00 M(-118.5%) |
| Mar 2019 | - | $1.06 B(-172.5%) | -$897.00 M(-55.1%) |
| Dec 2018 | -$2.00 B(+2930.3%) | -$1.46 B(+894.6%) | -$2.00 B(-515.8%) |
| Sep 2018 | - | -$147.00 M(-57.8%) | $481.00 M(-37.5%) |
| Jun 2018 | - | -$348.00 M(+709.3%) | $770.00 M(+719.1%) |
| Mar 2018 | - | -$43.00 M(-104.2%) | $94.00 M(-242.4%) |
| Dec 2017 | -$66.00 M(-104.5%) | $1.02 B(+617.6%) | -$66.00 M(-93.8%) |
| Sep 2017 | - | $142.00 M(-113.9%) | -$1.07 B(-32.3%) |
| Jun 2017 | - | -$1.02 B(+404.4%) | -$1.58 B(+959.7%) |
| Mar 2017 | - | -$203.00 M(-1368.8%) | -$149.00 M(-110.1%) |
| Dec 2016 | $1.48 B(-194.1%) | $16.00 M(-104.3%) | $1.48 B(+208.3%) |
| Sep 2016 | - | -$368.00 M(-190.6%) | $480.00 M(-38.9%) |
| Jun 2016 | - | $406.00 M(-71.5%) | $786.00 M(-187.3%) |
| Mar 2016 | - | $1.43 B(-244.9%) | -$900.00 M(-42.7%) |
| Dec 2015 | -$1.57 B(-229.3%) | -$984.00 M(+1487.1%) | -$1.57 B(+563.3%) |
| Sep 2015 | - | -$62.00 M(-95.2%) | -$237.00 M(+2054.5%) |
| Jun 2015 | - | -$1.28 B(-269.8%) | -$11.00 M(-95.5%) |
| Mar 2015 | - | $754.00 M(+114.8%) | -$242.00 M(-119.9%) |
| Dec 2014 | $1.22 B(-312.6%) | $351.00 M(+114.0%) | $1.22 B(+121.1%) |
| Sep 2014 | - | $164.00 M(-110.9%) | $550.00 M(-718.0%) |
| Jun 2014 | - | -$1.51 B(-168.3%) | -$89.00 M(-106.0%) |
| Mar 2014 | - | $2.21 B(-802.2%) | $1.48 B(-358.6%) |
| Dec 2013 | -$572.00 M(-91.5%) | -$315.00 M(-33.7%) | -$572.00 M(-2960.0%) |
| Sep 2013 | - | -$475.00 M(-933.3%) | $20.00 M(-100.5%) |
| Jun 2013 | - | $57.00 M(-64.6%) | -$3.71 B(+4.8%) |
| Mar 2013 | - | $161.00 M(-41.9%) | -$3.54 B(-47.4%) |
| Dec 2012 | -$6.73 B(+368.1%) | $277.00 M(-106.6%) | -$6.73 B(+3.3%) |
| Sep 2012 | - | -$4.20 B(-1959.7%) | -$6.51 B(+163.6%) |
| Jun 2012 | - | $226.00 M(-107.5%) | -$2.47 B(-18.4%) |
| Mar 2012 | - | -$3.03 B(-711.5%) | -$3.03 B(+110.6%) |
| Dec 2011 | -$1.44 B(-62.3%) | $495.00 M(-403.7%) | -$1.44 B(-67.4%) |
| Sep 2011 | - | -$163.00 M(-50.9%) | -$4.41 B(+33.7%) |
| Jun 2011 | - | -$332.00 M(-76.9%) | -$3.30 B(+20.9%) |
| Mar 2011 | - | -$1.44 B(-42.0%) | -$2.73 B(-28.4%) |
| Dec 2010 | -$3.81 B(-13.0%) | -$2.48 B(-361.5%) | -$3.81 B(+61.5%) |
| Sep 2010 | - | $948.00 M(+298.3%) | -$2.36 B(-55.4%) |
| Jun 2010 | - | $238.00 M(-109.4%) | -$5.30 B(-11.3%) |
| Mar 2010 | - | -$2.52 B(+145.3%) | -$5.97 B(+36.4%) |
| Dec 2009 | -$4.38 B(-186.2%) | -$1.03 B(-48.4%) | -$4.38 B(+92.2%) |
| Sep 2009 | - | -$1.99 B(+354.1%) | -$2.28 B(-163.0%) |
| Jun 2009 | - | -$438.00 M(-52.7%) | $3.62 B(+1.2%) |
| Mar 2009 | - | -$926.00 M(-186.2%) | $3.58 B(-29.6%) |
| Dec 2008 | $5.08 B(-2614.4%) | $1.07 B(-72.5%) | $5.08 B(+25.7%) |
| Sep 2008 | - | $3.91 B(-912.9%) | $4.04 B(+672.3%) |
| Jun 2008 | - | -$481.00 M(-183.5%) | $523.00 M(+42.5%) |
| Mar 2008 | - | $576.00 M(+1594.1%) | $367.00 M(-281.7%) |
| Dec 2007 | -$202.00 M | $34.00 M(-91.4%) | -$202.00 M(-140.1%) |
| Sep 2007 | - | $394.00 M(-161.9%) | $504.00 M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$637.00 M(-9200.0%) | -$2.00 M(-100.4%) |
| Mar 2007 | - | $7.00 M(-99.1%) | $490.00 M(+137.9%) |
| Dec 2006 | $206.00 M(-82.7%) | $740.00 M(-760.7%) | $206.00 M(-111.1%) |
| Sep 2006 | - | -$112.00 M(-22.8%) | -$1.86 B(+11.7%) |
| Jun 2006 | - | -$145.00 M(-47.7%) | -$1.66 B(>+9900.0%) |
| Mar 2006 | - | -$277.00 M(-79.1%) | -$15.00 M(-101.3%) |
| Dec 2005 | $1.19 B(-173.4%) | -$1.32 B(-1713.4%) | $1.19 B(-50.4%) |
| Sep 2005 | - | $82.00 M(-94.5%) | $2.40 B(+30.6%) |
| Jun 2005 | - | $1.50 B(+61.8%) | $1.84 B(-2143.3%) |
| Mar 2005 | - | $929.00 M(-922.1%) | -$90.00 M(-94.5%) |
| Dec 2004 | -$1.62 B(-32.9%) | -$113.00 M(-76.5%) | -$1.62 B(-34.9%) |
| Sep 2004 | - | -$480.00 M(+12.7%) | -$2.49 B(-1.6%) |
| Jun 2004 | - | -$426.00 M(-29.4%) | -$2.53 B(+5.5%) |
| Mar 2004 | - | -$603.00 M(-38.7%) | -$2.40 B(-0.7%) |
| Dec 2003 | -$2.42 B(+19.2%) | -$984.00 M(+88.9%) | -$2.42 B(-0.1%) |
| Sep 2003 | - | -$521.00 M(+77.2%) | -$2.42 B(+8.8%) |
| Jun 2003 | - | -$294.00 M(-52.6%) | -$2.23 B(+8.0%) |
| Mar 2003 | - | -$620.00 M(-37.1%) | -$2.06 B(+1.5%) |
| Dec 2002 | -$2.03 B(-58.3%) | -$986.00 M(+202.5%) | -$2.03 B(-200.1%) |
| Sep 2002 | - | -$326.00 M(+152.7%) | $2.03 B(-139.3%) |
| Jun 2002 | - | -$129.00 M(-78.1%) | -$5.16 B(+0.3%) |
| Mar 2002 | - | -$589.00 M(-119.2%) | -$5.14 B(+5.7%) |
| Dec 2001 | -$4.86 B(<-9900.0%) | $3.07 B(-140.9%) | -$4.86 B(-41.2%) |
| Sep 2001 | - | -$7.51 B(+6669.4%) | -$8.27 B(+1917.1%) |
| Jun 2001 | - | -$111.00 M(-64.2%) | -$410.00 M(+2.8%) |
| Mar 2001 | - | -$310.00 M(-7.5%) | -$399.00 M(-2593.8%) |
| Dec 2000 | $16.00 M(-102.1%) | -$335.00 M(-196.8%) | $16.00 M(+166.7%) |
| Sep 2000 | - | $346.00 M(-446.0%) | $6.00 M(-101.4%) |
| Jun 2000 | - | -$100.00 M(-195.2%) | -$415.00 M(-18.3%) |
| Mar 2000 | - | $105.00 M(-130.4%) | -$508.00 M(-33.1%) |
| Dec 1999 | -$759.00 M(+119.4%) | -$345.00 M(+360.0%) | -$759.00 M(+24.6%) |
| Sep 1999 | - | -$75.00 M(-61.1%) | -$609.00 M(-13.6%) |
| Jun 1999 | - | -$193.00 M(+32.2%) | -$705.00 M(+31.0%) |
| Mar 1999 | - | -$146.00 M(-25.1%) | -$538.00 M(+55.5%) |
| Dec 1998 | -$346.00 M(-35.0%) | -$195.00 M(+14.0%) | -$346.00 M(+15.3%) |
| Sep 1998 | - | -$171.00 M(+557.7%) | -$300.00 M(-10.7%) |
| Jun 1998 | - | -$26.00 M(-156.5%) | -$336.00 M(-4.3%) |
| Mar 1998 | - | $46.00 M(-130.9%) | -$351.00 M(-34.0%) |
| Dec 1997 | -$532.00 M(-25.8%) | -$149.00 M(-28.0%) | -$532.00 M(+18.5%) |
| Sep 1997 | - | -$207.00 M(+404.9%) | -$449.00 M(+27.6%) |
| Jun 1997 | - | -$41.00 M(-69.6%) | -$352.00 M(-34.9%) |
| Mar 1997 | - | -$135.00 M(+104.5%) | -$541.00 M(-24.5%) |
| Dec 1996 | -$717.00 M(+13.6%) | -$66.00 M(-40.0%) | -$717.00 M(-14.2%) |
| Sep 1996 | - | -$110.00 M(-52.2%) | -$836.00 M(-4.3%) |
| Jun 1996 | - | -$230.00 M(-26.0%) | -$874.00 M(+29.5%) |
| Mar 1996 | - | -$311.00 M(+68.1%) | -$675.00 M(+7.0%) |
| Dec 1995 | -$631.00 M(-55.7%) | -$185.00 M(+25.0%) | -$631.00 M(-9.6%) |
| Sep 1995 | - | -$148.00 M(+377.4%) | -$698.00 M(-50.5%) |
| Jun 1995 | - | -$31.00 M(-88.4%) | -$1.41 B(-9.6%) |
| Mar 1995 | - | -$267.00 M(+6.0%) | -$1.56 B(+9.6%) |
| Dec 1994 | -$1.42 B(+138.5%) | -$252.00 M(-70.7%) | -$1.42 B(+8.1%) |
| Sep 1994 | - | -$861.00 M(+378.3%) | -$1.32 B(+153.8%) |
| Jun 1994 | - | -$180.00 M(+37.4%) | -$519.00 M(+92.2%) |
| Mar 1994 | - | -$131.00 M(-9.7%) | -$270.00 M(-54.8%) |
| Dec 1993 | -$597.00 M(-238.8%) | -$145.00 M(+130.2%) | -$597.00 M(-223.1%) |
| Sep 1993 | - | -$63.00 M(-191.3%) | $485.00 M(+37.8%) |
| Jun 1993 | - | $69.00 M(-115.1%) | $352.00 M(+295.5%) |
| Mar 1993 | - | -$458.00 M(-148.9%) | $89.00 M(-79.3%) |
| Dec 1992 | $430.00 M(-24.7%) | $937.00 M(-578.1%) | $430.00 M(-169.8%) |
| Sep 1992 | - | -$196.00 M(+1.0%) | -$616.00 M(+56.7%) |
| Jun 1992 | - | -$194.00 M(+65.8%) | -$393.00 M(-235.5%) |
| Mar 1992 | - | -$117.00 M(+7.3%) | $290.00 M(-49.2%) |
| Dec 1991 | $571.00 M(-448.2%) | -$109.00 M(-503.7%) | $571.00 M(-1602.6%) |
| Sep 1991 | - | $27.00 M(-94.5%) | -$38.00 M(-60.8%) |
| Jun 1991 | - | $489.00 M(+198.2%) | -$97.00 M(-72.4%) |
| Mar 1991 | - | $164.00 M(-122.8%) | -$352.00 M(+114.6%) |
| Dec 1990 | -$164.00 M(-89.9%) | -$718.00 M(+2143.8%) | -$164.00 M(-129.6%) |
| Sep 1990 | - | -$32.00 M(-113.7%) | $554.00 M(-5.5%) |
| Jun 1990 | - | $234.00 M(-33.5%) | $586.00 M(+66.5%) |
| Mar 1990 | - | $352.00 M | $352.00 M |
| Dec 1989 | -$1.63 B | - | - |
FAQ
- What is Bristol-Myers Squibb annual cash flow from investing activities?
- What is the all time high annual CFI for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual CFI year-on-year change?
- What is Bristol-Myers Squibb quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly CFI year-on-year change?
- What is Bristol-Myers Squibb TTM cash flow from investing activities?
- What is the all time high TTM CFI for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb TTM CFI year-on-year change?
What is Bristol-Myers Squibb annual cash flow from investing activities?
The current annual CFI of BMY is -$21.35 B
What is the all time high annual CFI for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual cash flow from investing activities is $5.08 B
What is Bristol-Myers Squibb annual CFI year-on-year change?
Over the past year, BMY annual cash flow from investing activities has changed by -$19.06 B (-830.37%)
What is Bristol-Myers Squibb quarterly cash flow from investing activities?
The current quarterly CFI of BMY is -$196.00 M
What is the all time high quarterly CFI for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly cash flow from investing activities is $3.91 B
What is Bristol-Myers Squibb quarterly CFI year-on-year change?
Over the past year, BMY quarterly cash flow from investing activities has changed by +$1.15 B (+85.44%)
What is Bristol-Myers Squibb TTM cash flow from investing activities?
The current TTM CFI of BMY is -$21.35 B
What is the all time high TTM CFI for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high TTM cash flow from investing activities is $5.08 B
What is Bristol-Myers Squibb TTM CFI year-on-year change?
Over the past year, BMY TTM cash flow from investing activities has changed by -$19.06 B (-830.37%)